Investors & Media
Events & Presentations
Events
-
22/06/2021
GPW Innovation
-
11/06/2021
Discussion On Ryvu Data Presented at EHA 2021 – Conference Call
-
09/06/2021
EHA2021 Virtual Congress
-
09/06/2021
Synthetic lethality in cancer treatment – Ryvu Therapeutics seminar
-
04/06/2021
ASCO Annual Meeting 2021
-
26/05/2021
STING & TLR-Targeting Therapies Digital Summit
-
26/05/2021
Erste Group Innovation Conference 2021
-
25/05/2021
UBS Global Healthcare Virtual Conference
-
12/05/2021
Company’s quarterly report for I quarter of 2021
-
16/03/2021
Publication of the annual report for 2020
-
19/11/2020
Publication of Q3 2020 financial report
-
15/09/2020
Publication of H1 2020 financial report
-
14/09/2020
virtual
H.C Wainwright & Co. – 22nd Annual Global Investment Conference
-
10/06/2020
Publication of Q1 2020 financial report
-
16/04/2020
live.ryvu.com
Annual Financial Results 2019 video conference: Main Achievements in 2019 and Outlook for 2020 – 11.00 AM (CET) –
-
09/04/2020
Publication of Annual Report for 2019
-
02/04/2020
Solebury Trout Virtual Investor Conference
-
23/03/2020
Paris, France
BIO Europe Spring 2020
-
07/12/2019
Orlando, FL, USA
Ryvu Therapeutics at the 61st ASH Annual Meeting & Exposition
-
07/12/2019
Orlando, FL, USA
61st ASH Annual Meeting & Exposition
-
20/11/2019
London, UK
Jefferies London Healthcare Conference
-
11/11/2019
Hamburg, Germany
Ryvu Therapeutics presents at BIO-Europe 2019
-
06/11/2019
Consolidated quarterly Q3 2019 report publication
-
06/11/2019
National Harbor MD, USA
34th Annual Meeting & Pre-Conference Programs (SITC 2019)
-
10/08/2021
12th Annual Wedbush PacGrow Healthcare Conference
-
08/09/2021
Company’s semi-annual report for I half of 2021
-
09/09/2021
Morgan Stanley 19th Annual Global Healthcare Conference
-
13/09/2021
H.C. Wainwright 23rd Annual Global Investment Conference
-
10/11/2021
Company’s quarterly report for III quarter of 2021
Presentations
Ryvu Therapeutics
PDF
